Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
14 pending office actions • 9 art units • 14 examiners • 0 of 14 (0%) have an AI response strategy ready • 22 patents granted in the last 365 days
Kansas State University Research Foundation has 14 pending office actions in the Chemistry & Materials technology area. These actions are assigned to 14 distinct examiners, ensuring that each pending matter is reviewed by a different official. This distribution indicates that the foundation's chemical research spans many different sub-specialties, as 14 distinct examiners are required to cover the breadth of the active applications. The 14 pending actions represent the current active workload for the foundation's patent prosecution efforts.
The portfolio is active across 9 distinct art units, which suggests a broad technical range within the chemistry sector. BAZARGANI, ARYA AHMADI is the busiest examiner with 1 pending office action. With 14 pending actions and 9 art units, the foundation faces a complex prosecution environment where most cases are handled in unique departmental settings. This high count of 9 distinct art units relative to the total workload indicates that the foundation's chemical research is extremely specialized, involving 14 distinct examiners. Practitioners should focus on the 9 distinct art units to identify any shared procedural or substantive standards that might apply to the 14 pending office actions while addressing the individual concerns of 14 different examiners.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (14%) |
| §112 only | 1 (7%) |
| Double-patenting + other | 3 (21%) |
| Multi-statute (no §101) | 8 (57%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BAZARGANI, ARYA AHMADI | 1 | 62.5% | +31.3% |
| WANG, RUIXUE | 1 | 57.4% | +17.8% |
| DUFFY, PATRICIA ANN | 1 | 52.9% | +33.9% |
| SABILA, MERCY HELLEN | 1 | 57.0% | +46.4% |
| WATTS, JENNA A | 1 | 48.6% | +53.9% |
| NGUYEN, TAM M | 1 | 77.1% | +11.6% |
| SALVOZA, M FRANCO G | 1 | 68.4% | +30.0% |
| MATZEK, MATTHEW D | 1 | 46.3% | +36.8% |
| HAWKINS, AMANDA SALATA | 1 | 12.0% | +45.2% |
| OLSON, ANDREA STEFFEL | 1 | 62.3% | -11.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18697081 | RUTHENIUM PHOSPHINIMIDE COMPLEXES AS ACTIVE OLEFIN METATHESIS CATALYSTS | NGUYEN, TAM M | 33d |
| 18687858 | FIBER REINFORCED POLYMER AND METAL DUCTILITY FUSE FOR REINFORCING CONCRETE MEMBERS | MATZEK, MATTHEW D | 34d |
| 18924027 | DEVELOPMENT OF MOSAIC VACCINES AGAINST FOOT AND MOUTH DISEASE VIRUS SEROTYPE ASIA | WANG, RUIXUE | — |
| 18841203 | ANAPLASMA VACCINES AND METHODS OF USE THEREOF | DUFFY, PATRICIA ANN | — |
| 18720832 | ECO-FRIENDLY ADDITIVES FOR HAY AND SILAGE INOCULANTS MINIMIZING GREENHOUSE GAS EMISSIONS | WATTS, JENNA A | — |
| 18417359 | CHEMICAL MITIGANTS IN ANIMAL FEED AND FEED INGREDIENTS | HAWKINS, AMANDA SALATA | — |
| 18574630 | METHODS OF EXTRACTING CORN FIBER GUM AND USES IN EMULSION AND ENCAPSULATION | OLSON, ANDREA STEFFEL | — |
| 18476651 | ELECTROCHEMICAL CATALYSTS FOR FUEL CELLS AND METHODS OF MAKING AND USING THE SAME | BERNATZ, KEVIN M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18697081 | RUTHENIUM PHOSPHINIMIDE COMPLEXES AS ACTIVE OLEFIN METATHESIS CATALYSTS | NGUYEN, TAM M | 33d |
| 18687858 | FIBER REINFORCED POLYMER AND METAL DUCTILITY FUSE FOR REINFORCING CONCRETE MEMBERS | MATZEK, MATTHEW D | 34d |
| 18860868 | CORRALLING AMPHIPATHIC PEPTIDE COLLOIDS | BAZARGANI, ARYA AHMADI | — |
| 18924027 | DEVELOPMENT OF MOSAIC VACCINES AGAINST FOOT AND MOUTH DISEASE VIRUS SEROTYPE ASIA | WANG, RUIXUE | — |
| 18841203 | ANAPLASMA VACCINES AND METHODS OF USE THEREOF | DUFFY, PATRICIA ANN | — |
| 18722010 | CYCLIC PEPTIDE FOR CANCER IMMUNOTHERAPY | SABILA, MERCY HELLEN | — |
| 18720832 | ECO-FRIENDLY ADDITIVES FOR HAY AND SILAGE INOCULANTS MINIMIZING GREENHOUSE GAS EMISSIONS | WATTS, JENNA A | — |
| 18547842 | BOVINE VIRAL DIARRHEA VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF | SALVOZA, M FRANCO G | — |
| Art Unit | Apps |
|---|---|
| 1791 | 1 |
| 1771 | 1 |
| 1786 | 1 |
| 1793 | 1 |
| 1693 | 1 |
| 1735 | 1 |
| 3666 | 1 |
| 1614 | 1 |
| 2116 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18860868 | CORRALLING AMPHIPATHIC PEPTIDE COLLOIDS | BAZARGANI, ARYA AHMADI | — | §102§103§112DP | Non-Final OA | — | Pending | Oct 28, 2024 |
| 18924027 | DEVELOPMENT OF MOSAIC VACCINES AGAINST FOOT AND MOUTH DISEASE VIRUS SEROTYPE ASIA | WANG, RUIXUE | — | §102§103§112 | Non-Final OA | — | Pending | Oct 23, 2024 |
| 18841203 | ANAPLASMA VACCINES AND METHODS OF USE THEREOF | DUFFY, PATRICIA ANN | — | §102§112 | Non-Final OA | — | Pending | Aug 23, 2024 |
| 18722010 | CYCLIC PEPTIDE FOR CANCER IMMUNOTHERAPY | SABILA, MERCY HELLEN | — | §112 | Non-Final OA | — | Pending | Jun 20, 2024 |
| 18720832 | ECO-FRIENDLY ADDITIVES FOR HAY AND SILAGE INOCULANTS MINIMIZING GREENHOUSE GAS EMISSIONS | WATTS, JENNA A | 1791 | §102§103 | Non-Final OA | — | Pending | Jun 17, 2024 |
| 18697081 | RUTHENIUM PHOSPHINIMIDE COMPLEXES AS ACTIVE OLEFIN METATHESIS CATALYSTS | NGUYEN, TAM M | 1771 | §102§103§112 | Non-Final OA | 33d | Pending | Mar 29, 2024 |
| 18547842 | BOVINE VIRAL DIARRHEA VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF | SALVOZA, M FRANCO G | — | §103§112DP | Non-Final OA | — | Pending | Mar 18, 2024 |
| 18687858 | FIBER REINFORCED POLYMER AND METAL DUCTILITY FUSE FOR REINFORCING CONCRETE MEMBERS | MATZEK, MATTHEW D | 1786 | §102§103§112 | Non-Final OA | 34d | Pending | Feb 29, 2024 |
| 18417359 | CHEMICAL MITIGANTS IN ANIMAL FEED AND FEED INGREDIENTS | HAWKINS, AMANDA SALATA | 1793 | §103§112DP | Final Rejection | — | Pending | Jan 19, 2024 |
| 18574630 | METHODS OF EXTRACTING CORN FIBER GUM AND USES IN EMULSION AND ENCAPSULATION | OLSON, ANDREA STEFFEL | 1693 | §102§103§112 | Non-Final OA | — | Pending | Dec 27, 2023 |
| 18476651 | ELECTROCHEMICAL CATALYSTS FOR FUEL CELLS AND METHODS OF MAKING AND USING THE SAME | BERNATZ, KEVIN M | 1735 | §102§103 | Non-Final OA | — | Pending | Sep 28, 2023 |
| 18131739 | SYSTEM AND METHOD FOR AN AGRICULTURAL APPLICATOR | KWIATKOWSKA, LIDIA | 3666 | §103 | Final Rejection | 26d | Pending | Apr 06, 2023 |
| 17997276 | ENCAPSULATED COMPOSITIONS AND USE OF OCTENYLSUCCINIC ANHYDRIDE STARCH AS EMULSIFYING AGENT | PRAGANI, RAJAN | 1614 | §103 | Final Rejection | 31d overdue | Pending | Oct 27, 2022 |
| 17559397 | SYSTEM AND METHOD FOR AN AGRICULTURAL APPLICATOR | AHMED, ISTIAQUE | 2116 | §102§103 | Non-Final OA | — | Pending | Dec 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial